A Double-Blind Study Comparing Nimesulide with Naproxen in the Treatment of Osteoarthritis of the Hip.

作者: M. Quattrini , S. Paladin

DOI: 10.2165/00044011-199510030-00002

关键词: AnesthesiaDouble blind studyPharmacotherapyClinical efficacyNimesulideOsteoarthritisAdverse effectConcomitantMedicineNaproxen

摘要: 120 patients, aged between 45 and 87 years, with a history of osteoarthritic disease at least 12 months' duration unilateral or bilateral hip pain, were randomly allocated to treatment either nimesulide (100mg twice daily) naproxen (500mg for 4 weeks. Nimesulide was associated statistically significant improvement in the primary efficacy variable - pain intensity rest compared baseline (mean 71 % week 2, 80% 4; p & 0.01), concomitant number night awakenings, on active passive movement, morning stiffness impairment articular mobility movement. The global clinical end rated as good/fair by ≥ 85% patients doctor. For all variables assessed, there no difference naproxen. Four adverse events reported each group; they mild/moderate predominantly gastrointestinal nature. results this study confirm that is clinically effective suitable alternative short term osteoarthritis hip.

参考文章(17)
Hiroshi Shimeno, Hayami Debuchi, Akihisa Toda, Yasuaki Taniguchi, Tsutomu Nakamura, Atsutoshi Ikesue, Kazuyuki Yokoyama, Kanji Noda, Selective Inhibition by Nimesulide, a Novel Non‐steroidal Anti‐inflammatory Drug, with Prostaglandin Endoperoxide Synthase‐2 Activity In‐vitro Pharmacy and Pharmacology Communications. ,vol. 1, pp. 173- 175 ,(1995) , 10.1111/J.2042-7158.1995.TB00419.X
Abdulrhman Al Arfag, Paul Davis, Osteoarthritis 1991. Current drug treatment regimens. Drugs. ,vol. 41, pp. 193- 201 ,(1991) , 10.2165/00003495-199141020-00005
R.L. Dreiser, D. Concas Benevelli, Long term tolerability profile of nimesulide in the treatment of osteoarthritis. Drugs. ,vol. 46, pp. 270- 274 ,(1993) , 10.2165/00003495-199300461-00068
U. Marini, D. Spotti, E. Magni, T. Monti, Double-Blind Endoscopic Study Comparing the Effect of Nimesulide and Placebo on Gastric Mucosa of Dyspeptic Subjects Drug Investigation. ,vol. 2, pp. 162- 166 ,(1990) , 10.1007/BF03259190
Jeremy Hayllar, Andrew Macpherson, Ingvar Bjarnason, Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDS). Rationale and clinical implications. Drug Safety. ,vol. 7, pp. 86- 105 ,(1992) , 10.2165/00002018-199207020-00002